CALIFORNIA | LOCAL
July 17, 1989 |
Delivering estrogen through a melt-in-your-mouth tablet reduces the hot flashes of menopause without risking liver damage from larger doses that are required for pills that are swallowed, a study at the University of Southern California reports. The tablet dissolves over three to five minutes while held in the buccal, or hollow, cavity of the cheek. This allows the estrogen to enter the bloodstream through the cheek's mucous membrane rather than through the digestive system.
September 1, 1998 |
The new product was launched earlier this year in a fashion typical of top-notch pharmaceuticals: Fourteen years of studies, $25 million spent on research and development, 30 clinical trials ongoing worldwide and a $5-million marketing campaign featuring nationally known doctors as spokespeople. Only this is not a typical medication. Promensil, which was introduced in the United States in April, is a so-called "natural product" for the relief of menopausal symptoms.
January 6, 1994 |
France's conservative government said Wednesday that it will seek to impose strict controls on artificial impregnation, including a requirement that infertile couples have the consent of the sperm donor and a judge's permission before receiving an embryo implant. The government was spurred by a growing national debate this week following the birth of twins to a 59-year-old, post-menopausal British woman, who received an embryo implant at an Italian clinic.
May 16, 2011 |
"Fish out of water," Gladys said with pride as she took a seat in my office. "That's me. " No question, this full-figured, conservatively dressed woman in her 50s with salt-and-pepper hair was far different from most of her young and trendy screenwriting program classmates. Her past year had been a rough one: The unwelcome dissolution of her marriage of two decades and the departure of her adult children for higher education and work had fully emptied her nest. For the first time in more than 20 years, Gladys had no one to care for but herself.
June 24, 2007
Re "Doctors change course again on estrogen therapy," June 21 The Times' dramatic lead story on the latest findings from the Women's Health Initiative study creates the misimpression that there will be an important shift in treatment patterns based on this report. Although the data are reassuring in regard to heart disease risk from estrogen replacement in early menopause, the overall treatment issues in any given woman involve much more than just heart disease risk. As the article states, this study will primarily serve to reinforce the current standard practice: that estrogen should be used only for menopausal symptoms and that a low dose for the shortest treatment period is optimal.
CALIFORNIA | LOCAL
May 29, 1989 |
Most married women in their 60s not only desire sex but engage in it an average of five times a month, a survey of older women shows. "The news is good for all of us as we approach our 65th birthdays," said Dr. Gloria A. Bachman, a gynecologist at the University of Medicine and Dentistry of New Jersey. "We found sex is alive and well in older women." Bachman, in a report presented last week to the American College of Obstetricians and Gynecologists, said 59 older women were surveyed.
September 28, 1990 |
Calcium supplements can retard bone loss associated with osteoporosis, but only in older women who have been postmenopausal for at least five years and who have calcium-deficient diets, a study published in Thursday's New England Journal of Medicine reveals. Among women who have been postmenopausal five years or less, calcium supplements appear ineffective in preventing a very rapid phase of bone loss, said Dr.
December 14, 2008 |
Taking menopause hormones for five years doubles the risk for breast cancer, according to a new analysis of a big federal study that reveals the most dramatic evidence yet of the dangers of these popular pills. Even women who took estrogen and progestin pills for just a couple of years had a greater chance of getting cancer. But when they stopped, their odds quickly improved, returning to a normal risk level about two years later.
March 26, 2001 |
Women who take the hormone estrogen for 10 years or more after menopause substantially increase their risk of dying of ovarian cancer compared with women who do not take the hormone, according to a study released Tuesday. In the American Cancer Society study of more than 211,000 post-menopausal women, those with any history of using hormone replacement therapy had a somewhat higher death rate from ovarian cancer than nonusers.
CALIFORNIA | LOCAL
October 3, 1992 |
A 53-year-old grandmother is expected to give birth to twins in December at Martin Luther Hospital in Anaheim, making her one of the oldest women so far to become pregnant after menopause with the assistance of medical technology. Hospital spokesman Dennis Gaschen declined to identify the prospective mother until she is introduced at a press conference Monday.